Cited by 863Smoking Behavior and CessationLipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data.

Open access
Craig, W. Y., Palomaki, G. E., Haddow, J. E.·1989·BMJ

Abstract

To examine the association between cigarette smoking in adults and serum lipid and lipoprotein concentrations the results of 54 published studies were analysed. Overall, smokers had significantly higher serum concentrations of cholesterol (3.0%), triglycerides (9.1%), very low density lipoprotein cholesterol (10.4%), and low density lipoprotein cholesterol (1.7%) and lower serum concentrations of high density lipoprotein cholesterol (-5.7%) and apolipoprotein AI (-4.2%) compared with nonsmokers. Among non-smokers and light, moderate, and heavy smokers a significant dose response effect was present for cholesterol (0, 1.8, 4.3, and 4.5% respectively), triglycerides (0, 10.7, 11.5, and 18.0%), very low density lipoprotein cholesterol (0, 7.2, 44.4, and 39.0%), low density lipoprotein cholesterol (0, -1.1, 1.4, and 11.0%), high density lipoprotein cholesterol (0, -4.6, -6.3, and -8.9%), and apolipoprotein AI (0, -3.7 and -5.7% in non-smokers and light and heavy smokers). These dose response effects may provide new evidence for a causal relation between exposure to cigarette smoke and changes in serum lipid and lipoprotein concentrations whether as a direct result of physiological changes or of dietary changes induced by smoking. Adequate prospective data to estimate the excess risk of coronary artery disease existed only for cholesterol concentration. When that information was combined with data from the present study, and given that smokers as a group face an average overall excess risk of coronary artery disease of 70%, it was estimated that the observed increased serum cholesterol concentration in smokers may account for at least 9% of that excess risk. Furthermore, the dose response effect of smoking on serum cholesterol concentration suggests a gradient of increased absolute risk of coronary artery disease between light and heavy smokers.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.298.6676.784

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 16

  1. Topping DL. Effects of tobacco smoke and its constituents on lipid and carbohydrate metabolism. In: Clemens MJ, Ashwell M, eds. Biochemistry of cellular regulation. Vol 2. Boca Raton, Florida: CRC Press, 1980:165-83.
  2. Chen H, Zhuang H, Han Q. Serum high density lipoprotein cholesterol and factors iniflucencing its level in healthy Chinese. Atherosclerosis 19X3;48:71-9.
  3. Chiba K, Koizumi A, Kumai M, Watanabe ', Ikcda NI. Nationwide survev of high-denisity lipouprotein cholesterol among f'armers in Japan. Preve Med 1983;12:508-22.
  4. e I'arscau L, Fieldiiig CI. Abnormal plasma cholestcrol metabolism in cigarette smokers Metaibuolism 1986;35:1070-3.
  5. Dcdonder-Dccoopman E, Fievet-D)esreumeux C, Campus E, et al. I'lasma levels of verr low density lipoprotein t low density lipoprotein cholesterol, high denisity lipoprotcin cholestcrol, triglycerides and apoproteins B and A-I in a healthy population. Influence of sevcral risk l:actors. Atherosclerosis 1980;37:559-68. 211
  6. Donahue RP, Orchard 'I'J Stein EA, Kiiller LH. Apolipoprotcins A-I. A-IL ind B in young adults: associations with CHI) risk factors. 'he Beaver C(ounty cxperiencc . Chronic l)is 1986;39:823-30.
  7. Enger SC, Herb ctrnsen K, Erikssen J, Fretland A. High dcnsity lipoprotteins lHDL) and physical activity: the influence of' physical exercise, agc and smokitig oni high density lipoprotein cholesterol and the high density lipoprotein 'total cholesterol ratio. Scandf Clin Lab Invest 1977;37:251-5.
  8. Erikssen J, Enger SC. 'I'hc effect of smoking on selected coronary heart discase risk f'actors in mniddle-aged meni. Acta .Med Scand 1978;203:27-30.
  9. Fitrde OH, 'rhelc D)S, Arneson E, Nlos OD. Distribution of high density lipoprotcin cholcsterol according to relative body weight. cigarette smoking aild lcistirc tuin physical activity. 'I'he cardioxascular disease study in Fmilnmark 1977. Acta .ifdScand 1986;219: 167-71.
  10. lotman JW, Lindgren FT', Strisower B, deLalla 0, (ilazier F, I'amplin A. Cigarette smokitig, serum lipoproteins and corotnary heart disease. Geriairics 1955;10:349-54.
  11. Goldbourt U, Medalie JH. Characteristics of smokers, nonsmokers, and ex- smokers among 10000 adult males in Israel. 2. Physiologic, biochemical and genetic characteristics. Am] EIpidemiol 1977;105:75-86.
  12. Hcyden S, Heiss (G, Mancgold C, et al. 'I'he combined effect of smoking and -offee drinking on LDL and HI)L cholesterol. Circulation. 1979;60:22-5.
  13. Nesie LA, Mjos (1). IPlasma HD)L cholesterol and the subclasses HDL2 and HDL5 in smokers and niolsmokers. Artery 1985;13:7-18.
  14. OIsson AG, W'alldius G, Roissner S, Callmer E, Kal'iser I.. Studies on serum lipoproteins and lipid metabolism. Analysis of a random sample of 40 year old men. ,Acta Mtled Scand [Suppl] 1980;637:3-47.
  15. Hoinacki JL, Mulligan JJ, Cluette JE, Kew RR, Stack DJ, Huber GL. Effect of cigarette smoke and dietar-cholesterol on plasma lipoprotein composi- tion. Arterv 1981;9:285-304.
  16. Greenland S. Quantitatise methods in the review of epidemiologic literature. Epidemiol Rezv 1987;9: 1-30.

Cited by

Sorted by citations

Authors
Craig, W. Y., Palomaki, G. E., & Haddow, J. E.
Affiliations
Foundation for Blood Research (US)
Venue
BMJ
Publisher
BMJ
Published
1989-03-25
Volume
298
Issue
6676
Pages
784-788
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W2069204050
Cited by
863
References
60
Citations by year
2026: 10 · 2025: 15 · 2024: 15 · 2023: 14 · 2022: 39 · 2021: 24 · 2020: 31 · 2019: 25 · 2018: 33 · 2017: 27 · 2016: 27 · 2015: 23 · 2014: 46 · 2013: 25 · 2012: 43
FWCI
10.61
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
cigarette smoking, serum lipids, lipoproteins, serum cholesterol, triglycerides, LDL cholesterol, HDL cholesterol, apolipoprotein A-I, VLDL cholesterol, dose-response relationship, coronary artery disease risk, smoking intensity
MeSH terms
Apolipoproteins, Humans, Lipids, Lipoproteins, Cholesterol, HDL, Cholesterol, LDL, Smoking, Triglycerides, Meta-Analysis as Topic, Cholesterol, VLDL

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review